Synapse Open Synapse
Biology

Blood-based RNA biomarker for the early detection of ovarian cancer

Nature Medicine · · 1 min read

Tested in a cohort of 506 individuals, the RNA-based biomarker of microenvironment fitness Tu-stroma shows high performance in discriminating early-stage ovarian cancer from benign lesions, outperforming CA125.

Latest from Nature Medicine